Physician profile
Patrick T Fowler
NPI 1477628006
$1,729.11
in general payments reported to CMS, 2019-2025
16 companies · $269 in 2025
The $269 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.47 · 2020: $358 · 2021: $306 · 2022: $386 · 2023: $134 · 2024: $203 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.76 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $625.21 | 2019-2025 | Xtandi |
| Boston Scientific Corporation | $311.74 | 2021-2024 | Spaceoar System, Rezum Generator |
| Accord Healthcare, INC. | $233.73 | 2022-2025 | |
| Abbvie INC. | $114.86 | 2020-2025 | |
| Intuitive Surgical, INC. | $92.20 | 2022 | |
| Allergan, INC. | $57.87 | 2021-2022 | |
| Agiliti Surgical, INC. | $55.24 | 2022 | |
| Axonics, INC. | $45.40 | 2023-2024 | Axonics, Bulkamid |
| 180 Medical, INC. | $36.79 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $33.23 | 2021 | |
| Ferring Pharmaceuticals INC. | $24.27 | 2024 | Adstiladrin |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Cook Medical LLC | $22.99 | 2025 | S~Curve |
| C. R. Bard, INC. & Subsidiaries | $20.41 | 2020 | |
| Immunitybio, INC. | $15.75 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Fowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.